Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-24-244217
Filing Date
2024-10-25
Accepted
2024-10-25 17:12:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d903454dsc13d.htm SC 13D 31346
  Complete submission text file 0001193125-24-244217.txt   32659
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Subject) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93731 | Film No.: 241397840
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address
Louie Ngar Yee (Filed by) CIK: 0001913264 (see all company filings)

Type: SC 13D